患者分样比对用于初级医疗实验室质量保证的建议
本研究旨在为初级医疗实验室非实验室人员制定患者分样比对(POCT与中心实验室结果比较)的推荐。专家组基于文献、专业经验和Noklus教育框架,于2024年达成共识。推荐在无适宜EQA、室内质控不足或POCT结果与临床预期矛盾时进行比对,可接受限为15%或20%,超出限值需结构化核查。
要点
- 推荐在无EQA、室内质控不足或POCT与临床不符时进行患者分样比对。
- 比对可接受限为15%或20%,取决于被测量物。
- 超出可接受限的结果应使用结构化清单进行审查。
核心结论
- 首次发布针对初级医疗非实验室人员的患者分样比对建议,简单易用,便于推广。
研究设计与样本
- 2023年成立专家组,由检验医学专家、研究人员和实验室顾问组成,基于文献、专业经验和Noklus教育框架制定建议,草案经超过120名Noklus员工审核,2024年达成最终共识。
主要发现
- 推荐在以下情况比较POCT与中心实验室结果:无适宜EQA程序、室内质控材料缺乏或不充分、或POCT结果与临床预期矛盾。
关键数值与推荐
- 比对结果的可接受限设定为15%或20%,取决于被测量物。
- 超出可接受限的结果应使用结构化清单进行审查。
临床怎么用
- 初级医疗实验室非实验室人员可在上述三种情形下开展患者分样比对,并按15%或20%限值判断结果可接受性。
- 超出限值时按结构化清单审查,以识别和纠正问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The increasing adoption of point-of-care testing (POCT) in primary healthcare highlights the need for robust quality assurance (QA) procedures to ensure result reliability. The patient split sample approach, i.e. comparing POCT and central laboratory results from the same patient, can be a valuable QA tool, though practical guidance for its implementation remains scarce. This study aimed to develop clear, user-friendly recommendations for non-laboratory personnel in primary healthcare laboratories on when and how to perform such comparisons and to recommend acceptable limits for the compared results. METHODS: In 2023, an expert group was established, composed of medical specialists in laboratory medicine, researchers, and laboratory advisors. The recommendations were formulated based on relevant literature, the professional experience of the group members, and Noklus' educational framework for primary care laboratories. Pragmatic acceptability limits were established taking several approaches into account. The draft recommendations were audited among more than 120 Noklus employees and final consensus was reached in 2024. RESULTS: Comparing POCT results with central laboratory results is recommended when: (A) no suitable EQA program exists for a given POCT; (B) appropriate internal quality control materials are lacking or inadequate; or (C) POCT results contradict clinical expectations. Acceptable limits for the compared results were set at 15 or 20 %, depending on the measurand. Results outside these limits should be reviewed using a structured checklist. CONCLUSIONS: These are the first published recommendations for using patient split samples in primary healthcare that are designed to be simple and user-friendly for non-laboratory personnel, facilitating widespread adoption.
引用
- Stavelin A, Rønneseth E, Fossum AL, et al. Quality assurance using patient split samples: recommendations for primary healthcare laboratories. Clin Chem Lab Med. 2025. PMID: 40851551. doi:10.1515/cclm-2025-0818
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。